Neuron23

Manufacturing · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

343 Oyster Point Blvd Ste 120, South San...

Revenue

$10.6 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Neuron23

Neuron23 is a clinical-stage biotechnology company focused on developing precision medicine approaches to improve the lives of individuals with Parkinson's disease. By leveraging cutting-edge data science, human genetics, and innovative clinical strategies, the company aims to address the underlying causes of Parkinson's rather than just its symptoms. Their mission is to create breakthrough therapies that can significantly impact disease progression, particularly for genetically defined neurological conditions. Neuron23 is committed to transforming the treatment landscape for Parkinson's disease through personalized medicine.Explore more
Neuron23's Social MediaSIC Code 28,283NAICS Code 32,325Show more

Neuron23 Org Chart

Nancy Stagliano, Chief Executive Officer and Chair at Neuron23
United States flag for contact location.

Chief Executive Officer and Chair

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
LD
United States flag for contact location.

Senior VP, Translational Research & Discovery...

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
SD
United States flag for contact location.

Senior VP, Clinical Operations

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Neuron23

Compare insights from companies similar to Neuron23, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Neuron23

$10.6M
11-50
Private
$310M
2018
Nancy Stagliano, Chief Executive Officer and Chair at Neuron23
Nancy StaglianoCEO and Chair
$20M
51-200
Public
$496M
2018
HB
Harold BernsteinPresident, Research & Chief Medical Officer, Development
$16.9M
51-200
Private
$637M
2010
Peter Tummino, President, Research & Development at Nimbus Therapeutics
Peter TumminoPresident, Research & Development
$9.5M
11-50
Private
$133M
2015
WH
William HaneyCo-Founder & CEO
$7.6M
11-50
Private
-
2019
<$5M
11-50
Private
$12.9M
2006
AB
Angela BrightwellResearch Associate
<$5M
11-50
Private
$37M
2011
N/A
Illustration of an envelope

Neuron23 Tech Stack

A closer look at the technologies used by Neuron23

Top Manufacturing Companies

Frequently Asked Questions Regarding Neuron23

What is Neuron23's official website?
Neuron23's official website is www.neuron23.com
What is Neuron23's Revenue?
Neuron23's revenue is $10.6 Million
What is Neuron23's SIC code?
Neuron23's SIC: 28,283
What is Neuron23's NAICS code?
Neuron23's NAICS: 32,325
How many employees does Neuron23 have?
Neuron23 has 11-50 employees
What industry does Neuron23 belong to?
Neuron23 is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Neuron23 competition?
Neuron23 top competitors include: Maze Therapeutics, The Column Group, Nimbus Therapeutics, Lysosomal Therapeutics
What technology does Neuron23 use?
Some of the popular technologies that Neuron23 uses are: DocuSign, WordPress.org, reCAPTCHA, PHP
What does Neuron23 do?

Neuron23 is a clinical-stage biotechnology company focused on developing precision medicine approaches to improve the lives of individuals with Parkinson's disease. By leveraging cutting-edge data science, human genetics, and innovative clinical strategies, the company aims to address the underlying causes of Parkinson's rather than just its sympto... ms. Their mission is to create breakthrough therapies that can significantly impact disease progression, particularly for genetically defined neurological conditions. Neuron23 is committed to transforming the treatment landscape for Parkinson's disease through personalized medicine.Read More

What are Neuron23 social media links?
Neuron23 Linkedin page Neuron23 Twitter page
Who invested in Neuron23?
Neuron23 has 26 investors including HBM Partners, Cowen Healthcare Investments, Kleiner Perkins and Westlake Village BioPartners.
Is Neuron23 a public company?
Neuron23 is private company therefore does not currently have an official ticker symbol
See more information about Neuron23

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.